Verona Pharma plc
VRNA
$105.27
$0.070.07%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -81.19M | -163.94M | -173.42M | -153.72M | -125.45M |
| Total Depreciation and Amortization | 1.11M | 1.09M | 1.06M | 1.01M | 896.00K |
| Total Amortization of Deferred Charges | 2.65M | 2.16M | 1.59M | 1.08M | 401.00K |
| Total Other Non-Cash Items | 81.95M | 67.48M | 32.98M | 17.29M | 33.24M |
| Change in Net Operating Assets | -77.02M | -26.95M | 15.59M | 30.59M | 37.07M |
| Cash from Operations | -72.49M | -120.15M | -122.20M | -103.77M | -53.84M |
| Capital Expenditure | -1.07M | -1.10M | -580.00K | -45.00K | -45.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.07M | -1.10M | -580.00K | -45.00K | -45.00K |
| Total Debt Issued | 122.50M | 245.00M | 122.50M | 151.21M | 151.21M |
| Total Debt Repaid | 0.00 | -52.26M | -52.26M | -52.26M | -52.26M |
| Issuance of Common Stock | 112.20M | 107.25M | 102.90M | 4.48M | 864.00K |
| Repurchase of Common Stock | -124.61M | -126.09M | -15.45M | -15.88M | -9.74M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.61M | 93.45M | 93.09M | 93.07M | 97.69M |
| Cash from Financing | 105.47M | 267.36M | 250.78M | 180.63M | 187.77M |
| Foreign Exchange rate Adjustments | 1.51M | 427.00K | -11.00K | 1.85M | -11.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.42M | 146.53M | 127.99M | 78.67M | 133.87M |